Clinical Trial Update: Safety and Efficacy of an Antibody to CCR5 in Individuals With HIV Who Are Not Currently on Antiretroviral Therapy [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a CCR5-targeting antibody for safety and efficacy in people with HIV not currently on antiretroviral therapy; the study status is compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• CCR5 monoclonal antibody

Snippet

Sponsor: Human Genome Sciences Inc. | Conditions: HIV Infections | Phase 1 | Status: COMPLETED